Novel mutations in malonyl-CoA-acyl carrier protein transacylase provoke autosomal recessive optic neuropathy. (9th January 2020)

• Record Type: Journal Article
• Authors: Li, Huiping; Yuan, Shiqin; Minegishi, Yuriko; Suga, Akiko; Yoshitake, Kazutoshi; Sheng, Xunlun; Ye, Jianping; Smith, Stuart; Bunkoczi, Gabor; Yamamoto, Megumi; Iwata, Takeshi
• Is Part Of: Human molecular genetics. Volume 29:Number 3(2020)
• Page Start: 444
• Page End: 458
• Publication Date: 2020-01-09
• Subjects: Human molecular genetics -- Periodicals; Human chromosome abnormalities -- Periodicals; 572.8
• DOI: 10.1093/hmg/ddz311
• Languages: English
• ISSNs: 0964-6906

Abstract

Abstract: Inherited optic neuropathies are rare eye diseases of optic nerve dysfunction that present in various genetic forms. Previously, mutation in three genes encoding mitochondrial proteins has been implicated in autosomal recessive forms of optic atrophy that involve progressive degeneration of optic nerve and retinal ganglion cells (RGC). Using whole exome analysis, a novel double homozygous mutation p.L81R and pR212W in malonyl CoA-acyl carrier protein transacylase ( MCAT ), a mitochondrial protein involved in fatty acid biosynthesis, has now been identified as responsible for an autosomal recessive optic neuropathy from a Chinese consanguineous family. MCAT is expressed in RGC that are rich in mitochondria. The disease variants lead to structurally unstable MCAT protein with significantly reduced intracellular expression. RGC-specific knockdown of Mcat in mice, lead to an attenuated retinal neurofiber layer, that resembles the phenotype of optic neuropathy. These results indicated that MCAT plays an essential role in mitochondrial function and maintenance of RGC axons, while novel MCAT p.L81R and p.R212W mutations can lead to optic neuropathy.